UPLUNEP Trademark

Trademark Overview

On Monday, June 9, 2014, a trademark application was filed for UPLUNEP with the United States Patent and Trademark Office. The USPTO has given the UPLUNEP trademark a serial number of 86303656. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 6, 2024. This trademark is owned by Glaxo Group Limited. The UPLUNEP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
uplunep

General Information

Serial Number86303656
Word MarkUPLUNEP
Filing DateMonday, June 9, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 6, 2024
Registration Number5472366
Registration DateTuesday, May 22, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 6, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 6, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Thursday, June 12, 2014NEW APPLICATION ENTERED
Thursday, June 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 18, 2014ASSIGNED TO EXAMINER
Friday, September 19, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 26, 2014ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, September 29, 2014ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, October 15, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 4, 2014PUBLISHED FOR OPPOSITION
Tuesday, November 4, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 30, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 1, 2015SOU TEAS EXTENSION RECEIVED
Monday, June 1, 2015SOU EXTENSION 1 FILED
Monday, June 1, 2015SOU EXTENSION 1 GRANTED
Wednesday, June 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 18, 2015SOU TEAS EXTENSION RECEIVED
Wednesday, November 18, 2015SOU EXTENSION 2 FILED
Friday, December 11, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 15, 2015SOU EXTENSION 2 GRANTED
Wednesday, December 16, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 31, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, May 31, 2016SOU EXTENSION 3 FILED
Friday, June 10, 2016SOU EXTENSION 3 GRANTED
Saturday, June 11, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 6, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, December 6, 2016SOU EXTENSION 4 FILED
Saturday, January 7, 2017SOU EXTENSION 4 GRANTED
Tuesday, January 10, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 15, 2017SOU TEAS EXTENSION RECEIVED
Thursday, June 15, 2017SOU EXTENSION 5 FILED
Tuesday, June 27, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 3, 2017SOU EXTENSION 5 GRANTED
Tuesday, July 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 10, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, November 10, 2017NOTICE OF ALLOWANCE CANCELLED
Tuesday, January 30, 2018NOA CANCELLED; REPUBLICATION REQUIRED
Wednesday, February 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 6, 2018PUBLISHED FOR OPPOSITION
Tuesday, March 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 22, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 22, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, December 6, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

uplunep pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological